Prof. Shlomo Ben-Haim, MD, DSc
Shlomo Ben-Haim was a professor of Medicine, Physiology and Biophysics, with appointments both at Harvard and the Technion–Israel Institute of Technology. Ben-Haim also served as Chief Scientist for Johnson & Johnson’s Biosense-Webster. He has a formal education in the fields of nuclear physics, mathematics, biomedical engineering, philosophy, and medicine. Professor Ben-Haim has performed research in the field of medicine, published over 100 scientific papers in peer-reviewed journals, and is the recipient of a long list of prizes, including both the Juludan Prize for Biomedical Research, and the Andrea Gruntzig Award for Best Inventor. Professor Ben-Haim holds over 180 patents and patent applications, including a navigated cardiac catheterization system and an implantable device for treating congestive heart failure. He successfully co-founded a number of medical and biomedical start-up companies, and was a founding partner together with Lewis Pell in several companies including: Biosense (sold to Johnson & Johnson in 1997); Influence (sold to American Medical Systems, Inc. in 1999); Radiancy; Proteologics, and Exion Technologies (sold to Guidant in 2005). Professor Ben-Haim also founded Impulse Dynamics, a company that develops novel cardiac implantable devices. He continues to develop new and emerging technology companies with operations in both Israel and the US. These companies are dedicated to developing new technologies and products that address significant medical markets with unmet needs and high exit potentials, including type II diabetes, obesity, cardiac nuclear imaging, dry-freezing technologies (such as cell and organ freezing), peripheral arterial disease, and stroke rehabilitation.
Dr. David Helfet, MD
David L. Helfet, M.D. was born in Cape Town, Republic of South Africa on June 17, 1947. He completed his undergraduate studies at the University of Cape Town, receiving a BSc in Biochemistry with honors, followed by Medical School, where he received a M.B.CH.B. degree in 1975. Internship and Surgical Residency were completed at Edendale Hospital in Pietermaritzburg, S.A. and at Johns Hopkins University (JHU) in Baltimore, MD., followed by Orthopaedic Residency also at Johns Hopkins University, then fellowships at the University of Bern, Insel Hospital (1981) and at UCLA (1981- 82).
He was Assistant Professor of Orthopaedic Surgery at Johns Hopkins University School of Medicine (1/82 - 6/86), Associate Professor and Chief of Orthopaedic Trauma at the University of S. Florida School of Medicine/Tampa General Hospital (7/86-6/91) and at the Cornell University Medical College (7/91 - 6/98). He is currently Professor of Orthopaedic Surgery at the Weill Medical College of Cornell University and Director of the Combined Orthopaedic Trauma Service at both the Hospital for Special Surgery and New York-Presbyterian Hospital.
He has published and lectured extensively on Orthopaedic Trauma but especially on Fractures of the Pelvis and Acetabulum and has been the recipient of many honors, awards and visiting lectureships including the Presidential Guest and Watson-Jones Memorial Lecture of the British Orthopaedic Association in 1994.
He has served on several committees of the American Academy of Orthopaedic Surgeons, the AO/ASIF Foundation (currently the Chairman of AO Documentation and Publishing), AO North America and the American Board of Orthopaedic Surgery among others. In addition, Dr. Helfet has been extensively involved in the Orthopaedic Trauma Association, including as President (1998-1999) and is still on its Board as a past President.
Oren Gavriely
Oren Gavriely is an innovative mechanical engineer and has been actively involved with OHK since its inception in 1999, first as the Director of R&D, and then as Executive VP, where he oversaw production, marketing, regulatory and quality issues as well as the company’s day-to-day management. Mr. Gavriely was appointed OHK's CEO in January 2007. A prolific inventor in his own right, Mr. Gavriely has created over five invention families in various aspects of medical devices.
Dr. John H. Abeles, MD
Dr Abeles is General Partner of Northlea Partners, a medical and general investment concern, and President of MedVest Inc, a health sciences consulting firm. He had a career in the pharmaceutical industry and then as a health sciences analyst on Wall Street before forming both Northlea Partners and MedVest Inc.
Dr. Abeles recently served on the board of directors of I-Flow Corporation (recently acquired by Kimberly-Clark); and DUSA Pharmaceuticals, a publicly traded company. He currently is a director of Combimatrix and CytoCore, Inc. both public companies. He also is a director of several private companies: Alison Raffaele Cosmetics, BioStar, Unimedica, ContraFect, ALTHERA and MediSync BioSciences. He has helped to promulgate Encore Medical, acquired by Blackstone Capital and he was an early promulgator of InSound Corp, recently acquired privately by Sonova. Dr. Abeles obtained his medical degree and a degree in pharmacology from Birmingham University. He is a fellow of the Royal Society of Medicine and sits on advisory boards at the College of Chemistry, UC Berkeley and the Higuchi Institute at University of Kansas.
Prof. Noam Gavriely, MD
Professor Gavriely, the company’s founder and inventor of the HemaClear® exsanguination device, is a recognized authority in physiology and biophysics, and plays a major role in the commercialization of medical devices. Professor Gavriely graduated cum laude from the Technion-Israel Institute of Technology in Haifa, and did his post-doctoral training at the Harvard School of Public Health and the Brigham and Women's Hospital. Professor Gavriely was the head of the Pulmonary Physiology Department at the Technion's Rappaport Faculty of Medicine’s for 22 years. He is also the Co-Founder of Karmel Medical Acoustic Technologies Ltd (1996), Inspure Inc. (2003), ETView Ltd. (2004), and CardioAcoustics Ltd (2006).
Dr. Wayne Goldstein, MD
Dr. Goldstein is a specialist in hip and knee reconstruction and revision surgery in the suburban Chicago area. He has been in practice since 1983, and was also the President and Founder of the Illinois Bone and Joint Institute, Ltd in 1991. In the office setting, Dr. Goldstein sees 5,000 patients per year at two sites: Des Plaines and Morton Grove. He has performed research since 1973, and is the author of numerous publications. His research and experience have led him to independently and collaboratively design hip and knee replacement implants, both of which have proven to be a great success.
Dr. Jessie Jupiter, MD, MA
Jesse B. Jupiter, MD, MA is Professor of Orthopaedic Surgery at the Massachusetts General Hospital. He earned his M.D. at Yale in 1972 and completed his surgical internship at the University of Pennsylvania Hospital in 1973.
A two year commitment followed as a general medical officer in the United States Public Health Service Indian Health branch with the Pima Indians in Arizona. His interest in medical education was enhanced with the development of educational programs improving primary care for both diabetic and arthritic patients.
In 1975, he began a year of surgical residency at the Massachusetts General Hospital and a 3 ? year orthopaedic residency within the Harvard Combined Residency Program.
In 1980 Dr. Jupiter traveled to Basle, Switzerland where he completed an AO Fellowship and went on to a hand and microvascular fellowship in Louisville, Kentucky.
He returned to Boston in 1981 and began his academic and clinical career at the Massachusetts General Hospital. During his twenty-nine years on the academic faculty he has had the opportunity to head the Trauma Service, Foot and Ankle Program, and the Hand Service.
Dr. Jupiter is a well known and sought after hand specialist. He has given over five hundred scientific presentations worldwide and has written extensively on the subject.
Dr. Leslie S. Matthews, MD, MBA
Dr. Mathews is currently Chairman, Orthopedic Surgery, Union Memorial Hospital, Baltimore, MD. He received his BA from Johns Hopkins University (1969-1973), and his M.D. from Baylor College of Medicine, and his MBA from the Sellinger School of Business, Loyola College (2001-2003).
Dr. Mathews became Resident, General Surgery, Department of Orthopedic Surgery, at Johns Hopkins Hospital (1976-1979), and Fellow, Sports Medicine, Department of Orthopedic Surgery, Massachusetts General Hospital (1982).
Dr. Mathews is currently Chief of Orthopedic Surgery, Union Memorial Hospital, Baltimore, MD (1992-present), Director of Orthopedic Residency Training Program, Union Memorial Hospital (1992-present), Assistant Professor of Orthopedic Surgery, Johns Hopkins Hospital (1982-present), and Consulting Staff Physician, Orthopedic Surgery, Good Samaritan Hospital.
Dr. Mathews is a prior Member of the Board of Directors, Arthroscopy, Association of North America (1990-1993), the Sports Medicine Committee, American Academy Orthopedic Surgeons (1994–1998), and is currently a Member of the Johns Hopkins Medical and Surgical Society, the Arthroscopy Association of North America, the Baltimore City Medical Society, the Maryland Orthopedic Society, and an Active Member of the American Shoulder and Elbow Surgeons, the American Orthopedic Association, the American Orthopedic Society for Sports Medicine, and the Herodicus Society.
In an executive capacity, Dr. Mathews was Treasurer, Arthroscopy Association of North America (1993-1996), 2nd Vice President, Arthroscopy Association of North America (1996-1997), 1st Vice President, Arthroscopy Association of North America (1997-1998), President, Arthroscopy Association of North America (1998–1999), and).
Dr. Mathews is a Fellow of the American College of Surgeons and the American Academy of Orthopedic Surgeons.
Dr. Thomas Graham, MD
Dr. Graham is currently Chief, Curtis National Hand Center.
Dr. Graham is a Participating Physician of the Arnold Palmer Sports Health Center. His numerous specialties include: complex reconstructions of the hand, wrist and elbow, congenital hand surgery, total elbow replacement, contracture release, reconstruction for instability or nonunion, with a special focus on problems that typically affect an athlete’s throwing hand, from the wrist to the elbow.
Prof. Zvi Grunwald, MD
Dr. Grunwald is the currently Chief of Anesthesia, Jefferson, Philadelphia PA. Born in Israel and received his Medical Doctoral degree at the Hebrew University Medical School in Jerusalem (1982). Dr. Grunwald completed a residency in Pediatrics at the Beilinson Medical Center in Petah Tikva, Israel (1986) and his residency in Anesthesiology at the Hospital of the University of Pennsylvania, Philadelphia, PA. (1989). He also completed a fellowship in pediatric anesthesiology and critical care at the Children’s Hospital of Philadelphia (1989).
Dr. Grunwald was Assistant Professor of Anesthesiology at the University of Pennsylvania while serving as the director of anesthesia for liver and kidney transplantation at the Children’s Hospital of Philadelphia (1992-94). He served as the chairman for the department of Anesthesiology at the Rabin Medical Center in Petah Tikva, Israel (1995-96). Dr. Grunwald has participated and led the anesthesia teams at the first successful liver transplants at the Hospital of the University of Philadelphia, the Children’s Hospital of Philadelphia and in Israel. Currently Dr. Grunwald oversees the Jefferson Artificial Pancreas Center (APC), the first center that resides in an academic center at Thomas Jefferson University. The APC has been funded by the National Institutes of Health (NIH) since its inception under the leadership of Professor Jeffrey Joseph, a member of the Department of Anesthesiology. Dr. Grunwald and Dr. Joseph collaborated in the inception of Animas Corporation in 1997 to develop an implantable optical blood glucose sensor. Animas Corporation had a successful initial public offering in 2005 (NASDAQ symbol “PUMP”) and was acquired by Johnson & Johnson in 2006.
